S&P 500 7,686.14 â–ŧ 25.62 (-0.33%) DOW 53,185.90 â–ŧ 374.10 (-0.70%) NASDAQ 26,370.89 â–ŧ 31.53 (-0.12%) US Markets Closed â€ĸ 01:54 AM ET

HLN

Haleon plc

Price Chart

No historical data available

Latest Quote

$10.11

+0.07 (+0.70%)
Current Price
Previous Close $10.04
Open $10.04
Day High $10.11
Day Low $10.03
Volume 7,906,722
Fetched: 2026-08-31T06:53:27
Stock Information
Note: Financial values converted from GBP to USD
Quarterly Dividend / Yield $0.20 / 1.95%
Shares Outstanding 4.40B
Quarterly Dividend Yield 1.95%
Quarterly Dividend $0.20
Total Debt $11.18B
Cash Equivalents $1.12B
Revenue $15.10B
Net Income $2.20B
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Market Cap $44.46B
P/E Ratio 20.63
EPS (TTM) $0.49
Exchange NYQ
🌐 Visit Website
Recent Price History
No history data available. Data will be fetched automatically.
About Haleon plc

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc has a collaboration agreement with Microsoft to scale digital, data and AI capabilities across the business and accelerate delivery of its global win as one strategy. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

📰 Latest News
No news articles available at the moment. Check back later for updates on HLN.
Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $5,386,167,860 $6,012,054,201 $6,211,137,874 $5,837,515,091
Cost Of Revenue $5,386,167,860 $6,012,054,201 $6,211,137,874 $5,837,515,091
Total Revenue $15,040,362,404 $15,317,170,524 $15,411,258,014 $14,805,825,474
Operating Revenue $15,040,362,404 $15,317,170,524 $15,411,258,014 $14,805,825,474
Expenses
Interest Expense $473,164,620 $537,253,199 $564,524,935 $379,077,130
Total Expenses $11,751,391,042 $12,309,098,044 $12,689,538,761 $12,317,279,564
Net Non Operating Interest Income Expense $-415,893,974 $-462,255,925 $-545,434,720 $-299,989,096
Total Other Finance Cost $20,453,802 $13,635,868 $14,999,455 $5,454,347
Interest Expense Non Operating $473,164,620 $537,253,199 $564,524,935 $379,077,130
Operating Expense $6,365,223,182 $6,297,043,842 $6,478,400,887 $6,479,764,474
Other Operating Expenses $-16,363,042 $-179,993,458 $36,816,844 $-42,271,191
General And Administrative Expense $5,950,692,795 $6,070,688,434 $6,017,508,548 $6,112,959,624
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $2,273,099,196 $1,966,292,166 $1,430,402,553 $1,445,402,008
Net Interest Income $-415,893,974 $-462,255,925 $-545,434,720 $-299,989,096
Interest Income $77,724,448 $88,633,142 $34,089,670 $84,542,382
Normalized Income $2,225,196,239 $1,921,011,803 $1,400,643,635 $1,433,142,368
Net Income From Continuing And Discontinued Operation $2,273,099,196 $1,966,292,166 $1,430,402,553 $1,445,402,008
Total Operating Income As Reported $3,288,971,362 $3,008,072,481 $2,721,719,253 $2,488,545,910
Net Income Common Stockholders $2,273,099,196 $1,966,292,166 $1,430,402,553 $1,445,402,008
Net Income $2,273,099,196 $1,966,292,166 $1,430,402,553 $1,445,402,008
Net Income Including Noncontrolling Interests $2,290,825,824 $2,011,290,530 $1,514,944,935 $1,525,853,629
Net Income Continuous Operations $2,290,825,824 $2,011,290,530 $1,514,944,935 $1,525,853,629
Pretax Income $2,934,438,794 $2,604,450,788 $2,219,919,310 $2,206,283,442
Special Income Charges $70,906,514 $-9,545,108 $151,358,135 $-283,626,054
Interest Income Non Operating $77,724,448 $88,633,142 $34,089,670 $84,542,382
Operating Income $3,288,971,362 $3,008,072,481 $2,721,719,253 $2,488,545,910
Gross Profit $9,654,194,544 $9,305,116,323 $9,200,120,140 $8,968,310,384
Per Share
Diluted EPS $0.50 $0.43 $0.31 $0.31
Basic EPS $0.51 $0.43 $0.31 $0.31
Other
Tax Effect Of Unusual Items $13,458,450 $13,353,870 $13,875,859 $5,466,989
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $3,837,133,255 $3,524,871,878 $3,162,157,789 $2,958,983,356
Total Unusual Items $61,361,406 $58,634,232 $43,634,778 $17,726,628
Total Unusual Items Excluding Goodwill $61,361,406 $58,634,232 $43,634,778 $17,726,628
Reconciled Depreciation $490,891,248 $441,802,123 $421,348,321 $391,349,412
EBITDA (Bullshit earnings) $3,898,494,661 $3,583,506,110 $3,205,792,567 $2,976,709,984
EBIT $3,407,603,413 $3,141,703,987 $2,784,444,246 $2,585,360,573
Diluted Average Shares $6,153,867,228 $6,262,076,961 $6,329,214,837 $6,296,362,049
Basic Average Shares $6,123,868,319 $6,222,443,562 $6,273,695,409 $6,296,362,049
Diluted NI Availto Com Stockholders $2,273,099,196 $1,966,292,166 $1,430,402,553 $1,445,402,008
Otherunder Preferred Stock Dividend $0 $0 $0 $0
Minority Interests $-17,726,628 $-44,998,364 $-84,542,382 $-80,451,621
Tax Provision $643,612,970 $593,160,258 $704,974,376 $680,429,813
Other Special Charges $-70,906,514 $9,545,108 $-151,358,135 $283,626,054
Research And Development $430,893,429 $406,348,866 $424,075,495 $409,076,040
Selling General And Administration $5,950,692,795 $6,070,688,434 $6,017,508,548 $6,112,959,624
Fetched: 2026-08-25
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $-12,528,635,518 $-13,697,229,406 $-13,975,401,113 $-16,506,218,214
Total Assets $44,493,837,284 $46,791,481,042 $46,436,948,474 $47,473,274,442
Total Non Current Assets $38,289,517,344 $38,994,491,720 $39,867,187,272 $41,938,475,621
Other Non Current Assets $50,452,712 $96,814,663 $155,448,895 $179,993,458
Non Current Deferred Taxes Assets $394,076,585 $376,349,957 $361,350,502 $299,989,096
Financial Assets $12,272,281 $0 $88,633,142 $59,997,819
Goodwill And Other Intangible Assets $34,925,548,708 $35,740,973,615 $36,619,123,514 $38,774,954,245
Other Intangible Assets $23,843,678,785 $24,556,834,681 $25,278,172,098 $27,326,279,472
Current Assets $6,204,319,940 $7,796,989,322 $6,569,761,202 $5,534,798,821
Hedging Assets Current $106,359,770 $177,266,284 $31,362,496 $68,179,340
Restricted Cash $87,269,555 $74,997,274 $68,179,340 $106,359,770
Inventory $1,397,676,470 $1,622,668,292 $1,919,930,214 $1,838,115,006
Other Receivables $391,349,412 $430,893,429 $451,347,231 $537,253,199
Taxes Receivable $264,535,839 $332,715,179 $359,986,915 $130,904,333
Accounts Receivable $2,239,009,526 $2,165,375,838 $1,843,569,354 $2,027,653,572
Allowance For Doubtful Accounts Receivable $-57,270,646 $-49,089,125 $-39,544,017 $-55,907,059
Gross Accounts Receivable $2,296,280,171 $2,214,464,963 $1,883,113,371 $2,083,560,630
Cash Cash Equivalents And Short Term Investments $1,718,119,368 $2,993,073,026 $1,355,405,279 $826,333,601
Cash And Cash Equivalents $1,718,119,368 $2,993,073,026 $1,355,405,279 $826,333,601
Cash Financial $1,718,119,368 $2,993,073,026 $1,355,405,279 $826,333,601
Investmentin Financial Assets - $111,814,118 $0 -
Assets Held For Sale Current - $0 $539,980,373 $0
Prepaid Assets - - - $144,540,201
Non Current Deferred Assets - - - -
Receivables - - - -
Accrued Interest Receivable - - - -
Loans Receivable - - - -
Cash Equivalents - - - -
Debt
Net Debt $9,805,552,679 $10,614,159,651 $11,317,770,440 $13,189,975,116
Total Debt $11,705,029,091 $13,774,953,854 $12,859,987,111 $14,235,846,192
Long Term Debt And Capital Lease Obligation $10,565,070,526 $11,747,300,282 $11,965,474,170 $13,639,958,760
Long Term Debt $10,449,165,648 $11,647,758,446 $11,844,114,945 $13,480,419,105
Current Debt And Capital Lease Obligation $1,139,958,565 $2,027,653,572 $894,512,941 $595,887,432
Current Debt $1,074,506,398 $1,959,474,232 $829,060,774 $535,889,612
Other Current Borrowings - - - -
Liabilities
Total Liabilities Net Minority Interest $22,016,472,473 $24,668,648,799 $23,625,504,897 $25,032,726,474
Total Non Current Liabilities Net Minority Interest $15,289,898,788 $16,743,482,317 $17,298,462,145 $19,073,852,158
Other Non Current Liabilities $40,907,604 $38,180,430 $72,270,100 $29,998,910
Derivative Product Liabilities $46,361,951 $95,451,076 $204,538,020 $238,627,690
Non Current Deferred Taxes Liabilities $4,393,476,670 $4,572,106,540 $4,754,827,172 $4,910,276,067
Current Liabilities $6,726,573,684 $7,925,166,482 $6,327,042,752 $5,958,874,316
Payables $5,022,090,184 $4,952,547,258 $4,674,375,550 $4,655,285,335
Other Payable $1,790,389,468 $1,872,204,676 $1,685,393,285 $1,820,388,378
Total Tax Payable $425,439,082 $389,985,825 $459,528,752 $332,715,179
Accounts Payable $2,806,261,634 $2,690,356,756 $2,529,453,514 $2,502,181,778
Non Current Deferred Liabilities - - - -
Other Current Liabilities - - - -
Current Deferred Liabilities - - - -
Payables And Accrued Expenses - - - -
Equity
Common Stock Equity $22,396,913,190 $22,043,744,209 $22,643,722,401 $22,268,736,031
Total Equity Gross Minority Interest $22,477,364,811 $22,122,832,243 $22,811,443,577 $22,440,547,968
Stockholders Equity $22,396,913,190 $22,043,744,209 $22,643,722,401 $22,268,736,031
Retained Earnings $37,971,801,620 $37,187,739,210 $37,463,183,743 $36,448,675,164
Preferred Securities Outside Stock Equity $34,089,670 $34,089,670 $34,089,670 -
Gains Losses Not Affecting Retained Earnings - - - -
Other Equity Adjustments - - - -
Other
Treasury Shares Number $64,154,111 - - -
Ordinary Shares Number $12,143,157,152 $12,438,503,936 $12,592,142,980 $12,592,142,980
Share Issued $12,207,311,263 $12,438,503,936 $12,592,142,980 $12,592,142,980
Tangible Book Value $-12,528,635,518 $-13,697,229,406 $-13,975,401,113 $-16,506,218,214
Invested Capital $33,920,585,237 $35,650,976,886 $35,316,898,120 $36,285,044,748
Working Capital $-522,253,744 $-128,177,159 $242,718,450 $-424,075,495
Capital Lease Obligations $181,357,044 $167,721,176 $186,811,392 $219,537,475
Total Capitalization $32,846,078,838 $33,691,502,654 $34,487,837,346 $35,749,155,136
Minority Interest $80,451,621 $79,088,034 $167,721,176 $171,811,937
Treasury Stock $212,719,541 $158,176,069 $0 -
Additional Paid In Capital $2,727,174 $1,363,587 $0 $0
Capital Stock $122,722,812 $124,086,399 $125,449,986 $125,449,986
Common Stock $122,722,812 $124,086,399 $125,449,986 $125,449,986
Non Current Pension And Other Postretirement Benefit Plans $155,448,895 $178,629,871 $214,083,128 $219,537,475
Long Term Capital Lease Obligation $115,904,878 $99,541,836 $121,359,225 $159,539,656
Long Term Provisions $54,543,472 $77,724,448 $53,179,885 $35,453,257
Current Capital Lease Obligation $65,452,166 $68,179,340 $65,452,166 $59,997,819
Current Provisions $94,087,489 $160,903,242 $177,266,284 $96,814,663
Defined Pension Benefit $92,723,902 $49,089,125 $49,089,125 $34,089,670
Other Investments $91,360,316 $111,814,118 - -
Goodwill $11,081,869,924 $11,184,138,934 $11,340,951,416 $11,448,674,773
Net PPE $2,723,082,840 $2,619,450,243 $2,593,542,094 $2,589,451,333
Accumulated Depreciation $-2,132,649,755 $-1,949,929,124 $-1,733,118,823 $-1,655,394,375
Gross PPE $4,855,732,595 $4,569,379,367 $4,326,660,916 $4,244,845,708
Construction In Progress $529,071,678 $460,892,338 $508,617,876 $530,435,265
Other Properties $1,363,587 - $1,363,587 -
Machinery Furniture Equipment $2,765,354,030 $2,604,450,788 $2,350,823,643 $2,271,735,609
Buildings And Improvements $136,358,680 $124,086,399 $143,176,614 $174,539,110
Land And Improvements $1,423,584,619 $1,379,949,842 $1,322,679,196 $1,268,135,724
Properties $0 $0 $0 $0
Finished Goods $1,058,143,357 $1,265,408,550 $1,486,309,612 $1,367,677,560
Work In Process $9,545,108 $35,453,257 $27,271,736 $47,725,538
Raw Materials $329,988,006 $321,806,485 $406,348,866 $422,711,908
Available For Sale Securities - $111,814,118 - -
Employee Benefits - - - -
Current Deferred Revenue - - - -
Current Accrued Expenses - - - -
Dueto Related Parties Current - - - -
Duefrom Related Parties Current - - - -
Other Short Term Investments - - - -
Fetched: 2026-08-25
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $3,028,526,283 $2,703,992,624 $2,405,367,115 $2,365,823,098
Operating Activities
Operating Cash Flow $3,591,687,631 $3,137,613,227 $2,863,532,280 $2,813,079,568
Cash Flow From Continuing Operating Activities - - - -
Operating Gains Losses - - - -
Investing Activities
Capital Expenditure $-563,161,348 $-433,620,602 $-458,165,165 $-447,256,470
Investing Cash Flow $-471,801,033 $719,973,830 $-182,720,631 $-11,977,746,451
Cash Flow From Continuing Investing Activities - - - -
Financing Activities
Repurchase Of Capital Stock $-891,785,767 $-844,060,229 $0 $0
Financing Cash Flow $-4,285,753,312 $-2,095,832,912 $-2,138,104,102 $9,423,748,375
Net Other Financing Charges $-194,992,912 $-683,156,987 $-149,994,548 $494,982,008
Cash Dividends Paid $-834,515,122 $-777,244,476 $-529,071,678 $-3,657,139,798
Net Common Stock Issuance $-891,785,767 $-844,060,229 $0 $0
Common Stock Dividend Paid - - $-529,071,678 $-3,657,139,798
Cash Flow From Continuing Financing Activities - - - -
Other
Repayment Of Debt $-1,843,569,354 $-766,335,782 $-754,063,500 $-2,069,924,762
Issuance Of Debt $62,724,993 $1,655,394,375 $0 $15,004,909,147
End Cash Position $1,776,753,600 $3,009,436,068 $1,355,405,279 $833,151,535
Beginning Cash Position $3,009,436,068 $1,355,405,279 $833,151,535 $553,616,241
Effect Of Exchange Rate Changes $-66,815,753 $-107,723,357 $-20,453,802 $20,453,802
Changes In Cash $-1,165,866,714 $1,761,754,146 $542,707,546 $259,081,492
Interest Paid Cff $-486,800,488 $-490,891,248 $-550,889,067 $-222,264,648
Common Stock Payments $-891,785,767 $-844,060,229 $0 $0
Net Issuance Payments Of Debt $-1,780,844,361 $889,058,594 $-754,063,500 $12,934,984,385
Net Long Term Debt Issuance $-1,780,844,361 $889,058,594 $-754,063,500 $12,934,984,385
Long Term Debt Payments $-1,843,569,354 $-766,335,782 $-754,063,500 $-2,069,924,762
Long Term Debt Issuance $62,724,993 $1,655,394,375 $0 $15,004,909,147
Interest Received Cfi $81,815,208 $102,269,010 $36,816,844 $25,908,149
Net Investment Purchase And Sale $-8,181,521 $0 $0 $954,510,760
Purchase Of Investment $-8,181,521 $0 $0 -
Net Business Purchase And Sale $17,726,628 $608,159,713 $-96,814,663 $0
Sale Of Business $17,726,628 $608,159,713 $0 $0
Purchase Of Business $0 $0 $-96,814,663 $0
Net Intangibles Purchase And Sale $-124,086,399 $350,441,808 $196,356,499 $16,363,042
Sale Of Intangibles $0 $443,165,710 $335,442,353 $49,089,125
Purchase Of Intangibles $-124,086,399 $-92,723,902 $-139,085,854 $-32,726,083
Net PPE Purchase And Sale $-439,074,950 $-340,896,700 $-319,079,311 $-414,530,387
Purchase Of PPE $-439,074,950 $-340,896,700 $-319,079,311 $-414,530,387
Taxes Refund Paid $-598,614,605 $-808,606,972 $-606,796,126 $-441,802,123
Change In Working Capital $349,078,221 $280,898,881 $-145,903,788 $246,809,211
Change In Other Current Assets $85,905,968 $196,356,499 $-171,811,937 $233,173,343
Change In Payable $170,448,350 $215,446,714 $152,721,722 $527,708,092
Change In Inventory $181,357,044 $294,534,749 $-178,629,871 $-398,167,346
Change In Receivables $-88,633,142 $-425,439,082 $51,816,298 $-115,904,878
Other Non Cash Items $392,712,998 $391,349,412 $486,800,488 $294,534,749
Stock Based Compensation $117,268,465 $139,085,854 $103,632,597 $20,453,802
Deferred Tax $643,612,970 $593,160,258 $704,974,376 $680,429,813
Depreciation And Amortization $490,891,248 $441,802,123 $421,348,321 $391,349,412
Amortization Cash Flow $163,630,416 $134,995,093 $147,267,374 $145,903,788
Depreciation $327,260,832 $306,807,030 $274,080,947 $245,445,624
Pension And Employee Benefit Expense $-99,541,836 $1,363,587 $95,451,076 $-58,634,232
Gain Loss On Investment Securities $-58,634,232 $-50,452,712 - -
Gain Loss On Sale Of PPE $0 $-9,545,108 $16,363,042 $-40,907,604
Gain Loss On Sale Of Business $0 $-164,994,003 $0 $0
Net Income From Continuing Operations $2,290,825,824 $2,011,290,530 $1,514,944,935 $1,525,853,629
Sale Of Investment - $0 $0 $954,510,760
Sale Of PPE - - $0 $0
Change In Other Working Capital - - - -
Change In Payables And Accrued Expense - - - -
Change In Account Payable - - - -
Changes In Account Receivables - - - -
Asset Impairment Charge - - - -
Deferred Income Tax - - - -
Depreciation Amortization Depletion - - - -
Amortization Of Intangibles - - - -
Fetched: 2026-08-25